메뉴 건너뛰기




Volumn 89, Issue 5, 2006, Pages 632-637

Levodopa induced motor complications in Thai Parkinson's disease patients

Author keywords

Levodopa; Motor complications; Parkinson's disease; Thailand

Indexed keywords

CATECHOL METHYLTRANSFERASE INHIBITOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

EID: 33646820710     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (5)

References (19)
  • 2
    • 0347722578 scopus 로고    scopus 로고
    • Unmet medical needs in Parkinson's disease
    • Koller WC, Tse W. Unmet medical needs in Parkinson's disease. Neurology 2004; 62(Suppl 1): S1-8.
    • (2004) Neurology , vol.62 , Issue.1 SUPPL.
    • Koller, W.C.1    Tse, W.2
  • 3
    • 0034684139 scopus 로고    scopus 로고
    • Pramipexole vs. levodopa as initial treatment for Parkinson's disease
    • Parkinson Study Group. Pramipexole vs. levodopa as initial treatment for Parkinson's disease. JAMA 2000; 284: 1931-8.
    • (2000) JAMA , vol.284 , pp. 1931-1938
  • 4
    • 0030778373 scopus 로고    scopus 로고
    • Entacapone improves motor fluctuations in levodopa-treated Parkinson's disease patients
    • Parkinson Study Group. Entacapone improves motor fluctuations in levodopa-treated Parkinson's disease patients. Ann Neurol 1997; 42: 747-55.
    • (1997) Ann Neurol , vol.42 , pp. 747-755
  • 5
    • 0026514953 scopus 로고
    • Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases
    • Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-4.
    • (1992) J Neurol Neurosurg Psychiatry , vol.55 , pp. 181-184
    • Hughes, A.J.1    Daniel, S.E.2    Kilford, L.3    Lees, A.J.4
  • 7
  • 8
    • 8044229410 scopus 로고    scopus 로고
    • Comparison of immediate-release and controlled release carbidopa/levodopa in Parkinson's disease. A multicenter 5-year study
    • The CR First Study Group
    • Block G, Liss C, Reines S, Irr J, Nibbelink D. Comparison of immediate-release and controlled release carbidopa/levodopa in Parkinson's disease. A multicenter 5-year study. The CR First Study Group. Eur Neurol 1997; 37: 23-7.
    • (1997) Eur Neurol , vol.37 , pp. 23-27
    • Block, G.1    Liss, C.2    Reines, S.3    Irr, J.4    Nibbelink, D.5
  • 9
    • 9044226896 scopus 로고    scopus 로고
    • Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa
    • Parkinson Study Group. Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa. Ann Neurol 1996; 39: 37-45.
    • (1996) Ann Neurol , vol.39 , pp. 37-45
  • 12
    • 20844444331 scopus 로고    scopus 로고
    • Evidence-based medical review update: Pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004
    • Goetz CG, Poewe W, Rascol O, Sampaio C. Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004. Mov Disord 2005; 20: 523-39.
    • (2005) Mov Disord , vol.20 , pp. 523-539
    • Goetz, C.G.1    Poewe, W.2    Rascol, O.3    Sampaio, C.4
  • 14
    • 13744253467 scopus 로고    scopus 로고
    • Efficacy and safety of Piribedil in early combination with L-dopa in the treatment of Parkinson's disease: A 6-month open study
    • Suwantamee J, Nidhinandana S, Srisuwananukorn S, Laptikultham S, Pisarnpong A, Chankrachang S, et al. Efficacy and safety of Piribedil in early combination with L-dopa in the treatment of Parkinson's disease: a 6-month open study. J Med Assoc Thai 2004; 87: 1293-300.
    • (2004) J Med Assoc Thai , vol.87 , pp. 1293-1300
    • Suwantamee, J.1    Nidhinandana, S.2    Srisuwananukorn, S.3    Laptikultham, S.4    Pisarnpong, A.5    Chankrachang, S.6
  • 15
    • 19344378940 scopus 로고    scopus 로고
    • Entacapone in the treatment of Parkinson's disease
    • Schrag A. Entacapone in the treatment of Parkinson's disease. Lancet Neurol 2005; 4: 366-70.
    • (2005) Lancet Neurol , vol.4 , pp. 366-370
    • Schrag, A.1
  • 16
    • 0033955806 scopus 로고    scopus 로고
    • Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease
    • Giladi N, Treves TA, Paleacu D, Shabtai H, Orlov Y, Kandinov B, et al. Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease. J Neural Transm 2000; 107: 59-71.
    • (2000) J Neural Transm , vol.107 , pp. 59-71
    • Giladi, N.1    Treves, T.A.2    Paleacu, D.3    Shabtai, H.4    Orlov, Y.5    Kandinov, B.6
  • 17
    • 0036169364 scopus 로고    scopus 로고
    • The heterogeneity of idiopathic Parkinson's disease
    • Foltynie T, Brayne C, Barker RA. The heterogeneity of idiopathic Parkinson's disease. J Neurol 2002; 249: 138-45.
    • (2002) J Neurol , vol.249 , pp. 138-145
    • Foltynie, T.1    Brayne, C.2    Barker, R.A.3
  • 18
    • 0036202684 scopus 로고    scopus 로고
    • Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease
    • Jellinger KA, Seppi K, Wenning GK, Poewe W. Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease. J Neural Transm 2002; 109: 329-39.
    • (2002) J Neural Transm , vol.109 , pp. 329-339
    • Jellinger, K.A.1    Seppi, K.2    Wenning, G.K.3    Poewe, W.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.